"Farmer Mike" Valladao has been carving giant pumpkins for nearly 40 years, starting in 1984 when he saw the world's largest pumpkin at a festival in Half Moon Bay, Calif. He started growing his own ...

The French automaker introduced the refreshed Citroën C4 Picasso in the summer of 2016, three years after the launch of the car's second generation, and the updated model added a more dynamic look and ...

CERTAIN prominent European carmakers — with the French to the fore — see a superhighway to the future populated by driverless cars packed with gizmos and gadgets. That is the only possible conclusion ...

The 2009 Citroen C4 Exclusive is a front-wheel drive, 5-door Hatchback that was released to the Australian market on 2nd March 2009. The Citroen C4 is regarded as a small car built in France with ...

The 2014 Citroen C4 is a small car offered in a 5D hatchback body style. Used prices in Australia typically range from $20,990 for the Attraction variant and topping out at $33,490 for the Exclusive.

As you pore over your Grand C4 Picasso options, and if you’re after one with an automatic gearbox, you may wonder what ETG6 and EAT6 mean. They’re actually two distinctly different types of automatic ...

Year Body Type Height x Width x Length Ground Clearance The Citroen Grand C4 Picasso has a number of different wheel and tyre options. When it comes to tyres, these range from 205x55 R17 for Wagon in ...

This is a review of a new Citroen C4 Cactus. It was replaced by the Mk3 Citroen C4 in 2020. You can read our Citroen C4 Cautus used buying guide here... The Citroen C4 Cactus represents a return to ...

Feb 15 (Reuters) - Carmaker Stellantis (STLAM.MI), opens new tab halted production in Russia in April 2022. But the decision did not stop Russian operators from joining forces with a Chinese partner ...

C4 Therapeutics Inc (NASDAQ:CCCC) has entered into an exclusive license and collaboration agreement with Merck & Co Inc (NYSE:MRK) to develop degrader-antibody conjugates (DACs), an emerging modality ...

C4 Therapeutics and Betta Pharmaceuticals will swim together to commercialize a lung cancer med in greater China in a deal worth $10 million in upfront cash and a possible $357 million down the line.